Hantz Financial Services’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35K Sell
529
-341
-39% -$28.9K ﹤0.01% 1789
2026
Q1
$86K Buy
870
+559
+180% +$72.9K ﹤0.01% 1337
2025
Q4
$38K Buy
311
+206
+196% +$25.9K ﹤0.01% 1547
2025
Q3
$12K Buy
105
+91
+650% +$10.7K ﹤0.01% 1778
2025
Q2
$2K Buy
14
+12
+600% +$1.32K ﹤0.01% 2032
2025
Q1
$0 Buy
+2
New +$138 ﹤0.01% 1968
2021
Q3
Sell
-15
Closed 859
2021
Q2
$0 Buy
+15
New +$416 ﹤0.01% 844

Other funds holding TMDX

Hantz Financial Services's TMDX Position: Q2 2026 in Review

Hantz Financial Services reduced its Transmedics (TMDX) stake by 39% in Q2 2026, selling an estimated $28.9K and leaving 529 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #1789.

Hantz Financial Services first reported a position in TMDX in Q2 2021 and has held it in 7 quarters since. The position peaked at $86K in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Hantz Financial Services held 529 shares of Transmedics worth $35K as of Q2 2026.
  • Hantz Financial Services sold 341 Transmedics shares in Q2 2026, an estimated $28.9K.
  • Transmedics made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1789 holding.
  • Hantz Financial Services first reported a position in Transmedics in Q2 2021 and has held it in 7 quarters since.
  • Hantz Financial Services's Transmedics position peaked at $86K in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.